nature cell biology volume 10 | number 10 | oCTober 2008 RT-PCR. RNA extraction, reverse transcription, PCR, the primer sequence for Xsiamois, Xnr3 and ODC, and PCR conditions have been described previously 31 . RNA (2.8 μg, measured by Nanodrop; Thermo Fischer Scientific) was used for cDNA preparation.
The von Hippel-Lindau protein pVHL suppresses renal tumorigenesis in part by promoting the degradation of hypoxia-inducible HIF-α transcription factors 1 ; additional mechanisms have been proposed 2 . pVHL also stabilizes the plant homeodomain protein Jade-1, which is a candidate renal tumour suppressor that may correlate with renal cancer risk [3] [4] [5] .
Here we show that Jade-1 binds the oncoprotein β-catenin in Wnt-responsive fashion. Moreover, Jade-1 destabilizes wildtype β-catenin but not a cancer-causing form of β-catenin. Whereas the well-established β-catenin E3 ubiquitin ligase component β-TrCP ubiquitylates only phosphorylated β-catenin 6 , Jade-1 ubiquitylates both phosphorylated and non-phosphorylated β-catenin and therefore regulates canonical Wnt signalling in both Wnt-off and Wnt-on phases. Thus, the different characteristics of β-TrCP and Jade-1 may ensure optimal Wnt pathway regulation. Furthermore, pVHL downregulates β-catenin in a Jade-1-dependent manner and inhibits Wnt signalling, supporting a role for Jade-1 and Wnt signalling in renal tumorigenesis. The pVHL tumour suppressor and the Wnt tumorigenesis pathway are therefore directly linked through Jade-1.
To identify molecular mediators of Jade-1 activity, we screened a human kidney complementary DNA library with a yeast two-hybrid approach using a transcriptionally inactive truncation of Jade-1 lacking both plant homeodomains (PHDs) (Jade-1 dd) as bait ( Supplementary  Information, Fig. S1a ). Nine strong interactors were found, including β-catenin, an oncoprotein and the key transcriptional co-activator of canonical Wnt signalling 7 .
The Jade-1-β-catenin interaction was confirmed in mammalian cells by co-immunoprecipitation (Fig. 1a) . The localization and fate of β-catenin depend on Wnt status 7 . Constitutively, in Wnt-off phase, β-catenin is phosphorylated by glycogen synthase kinase (GSK)-3β, binds to the destruction complex in the cytosol and is degraded. In Wnt-on phase, GSK-3β is inhibited; β-catenin dissociates from the destruction complex and translocates to the nucleus. We therefore examined the binding of endogenous Jade-1 and β-catenin during the different states of Wnt signalling. Wnt signalling was activated by using Wnt-3a ligand or lithium chloride (an inhibitor of GSK-3β that mimics Wnt activation) and inhibited by using Wnt-3a plus dickkopf 1 (DKK1), a competitive antagonist of Wnt-3a ( Fig. 1b and Supplementary Information, Fig. S1b ). Endogenous Jade-1 co-immunoprecipitated with endogenous β-catenin, and vice versa ( Fig. 1b) . However, the Jade-1-β-catenin interaction was increased in vehicle-treated and Wnt-3a-DKK1-treated cells (Wnt-off phase) in comparison with Wnt-3a-treated cells (Wnt-on phase). Co-localization and profile plots were performed to demonstrate the distribution and abundance of the proteins (Fig. 1c ). In Wnt-off phase (Fig. 1c , vehicle-treated), β-catenin was predominantly in the cytosol and cell membrane. Jade-1 was in the cytosol and nucleus, excluding nucleoli 3, 8 . Jade-1 and β-catenin were co-localized in the cytosol. Treatment with Wnt-3a resulted in nuclear translocation of β-catenin. However, Jade-1 and β-catenin had different sub-compartmental localizations in the nucleus (Fig. 1c , Wnt-3a-treated), resulting in a decrease in co-localization. Thus, endogenous Jade-1 and endogenous β-catenin interact, and the interaction is greater in Wnt-off phase than in Wnt-on phase.
Jade-1 interacted specifically with the amino terminus of β-catenin ( Fig. 1d ). Jade-1 showed decreased binding to a naturally occurring, cancer-causing, constitutively active (CA) S33A mutant of β-catenin lacking this GSK-3β phosphorylation site (Fig. 1d ). These findings were confirmed by immunofluorescence microscopy of cells expressing Flag-tagged Jade-1 and a Myc-tagged β-catenin series ( Supplementary  Information, Fig. S1c-e ). In Wnt-off phase, Jade-1 co-localized extensively with wild-type β-catenin and the carboxy-terminally truncated β-catenin predominantly in the cytosol, but not with β-catenin S33A or the N-terminally truncated β-catenin ( Supplementary Information,  Fig. S1d ). In contrast, in Wnt-on phase, wild-type β-catenin localized to the nucleus, thereby decreasing co-localization with Jade-1 (Supplementary Information, compare Fig. S1d with Fig. S1e ), which is consistent with the reduction in endogenous Jade-1-β-catenin binding with Wnt activation. These data indicate that β-catenin N-terminal serine residue 33, or its phosphorylation, is important for optimal binding to Jade-1. We examined the binding of purified recombinant glutathione S-transferase (GST)-tagged Jade-1 and GSTtagged β-catenin in in vitro GST pull-down assays. GST-tagged Jade-1 associated with GST-tagged β-catenin ( Supplementary Information,  Fig. S1f ). However, this binding was substantially increased after in vitro phosphorylation of β-catenin by the kinases casein kinase 1 and GSK-3β ( Supplementary Information, Fig. S1f ). GST-tagged Jade-1 did not bind to the N-terminally deleted β-catenin. Overall, Jade-1 directly binds the N terminus of β-catenin, and the interaction is enhanced with β-catenin phosphorylation in Wnt-off phase.
In Wnt-off phase, β-catenin is degraded in a process that depends on the β-catenin N terminus or 'degron' 7, 9 . Jade-1 interacts with the N terminus of β-catenin and, in particular, residue S33 ( Supplementary  Information, Fig. S1a ). We therefore examined whether Jade-1 regulates the abundance of β-catenin. Jade-1 downregulated wild-type β-catenin and a C-terminally deleted β-catenin ( Fig. 2a ). However, Jade-1 had little effect on an N-terminally deleted β-catenin or β-catenin S33A, which is consistent with the binding pattern of Jade-1 with β-catenin ( Fig. 1d) .
Endogenous β-catenin exists in three distinct cellular pools 7 . The quantity of endogenous β-catenin protein in the cytosolic and nuclear fractions in three different Jade-1-silenced cell lines was at least double that in empty-vector lines ( Fig. 2b and Supplementary Information, Fig. S2b-d) . The membrane pool of β-catenin was unchanged. Conversely, the amount of β-catenin in the cytosolic and nuclear fractions was substantially lower in Jade-1-expressing stable cell lines than in the empty-vector cell lines (Fig. 2c ). We then examined the half-life of cytosolic β-catenin. A digitonin-extracted fraction 10 was enriched for cytosol, as demonstrated by the increase in cytosolic markers, but had no membrane contamination ( Supplementary Information, Fig. S2e ). The half-life of the digitonin-extracted cytosolic β-catenin was increased from 10 min to 90 min in Jade-1-silenced 293 cell lines ( Fig. 2d ). Thus, Jade-1 silencing substantially stabilized cytosolic β-catenin. The half-life of β-catenin was decreased in the Jade-1-expressing renal cancer cell 
Figure 1
Jade-1 and β-catenin interact. (a) In vivo interaction of Jade-1 and β-catenin. Extracts (600 μg of protein) from transiently transfected 293T cells were immunoprecipitated (IP) with 1 μg of monoclonal Myc-tag or Flag-tag antibodies. Co-immunoprecipitated β-catenin or Jade-1 was detected by immunoblotting (IB). Whole cell lysates (10%) were probed for input. Representative immunoblot of four experiments. (b) The interaction of endogenous Jade-1 and endogenous β-catenin is increased in Wnt-off phase. IPs were performed with whole cell lysates of 293T cells pretreated with vehicle (PBS + 0.1% BSA) or 50 ng of Wnt-3a ligand with or without 50 ng of DKK1, using 1 μg of either polyclonal anti-Jade-1 antibody (J1) or preimmune serum (C). β-Catenin was immunoprecipitated with monoclonal anti-β-catenin antibody (β-cat.) or isotype control (C). Jade-1 was detected with Jade-1 antiserum. Whole cell lysates (10%) were probed for input. The amounts of Jade-1 and β-catenin immunoprecipitated were normalized with IgG. Representative immunoblot of three experiments. Numbers at the left of gels are relative molecular weights. (c) Co-localization of endogenous Jade-1 and endogenous β-catenin is increased in Wnt-off phase. The 293T cells pretreated with vehicle or Wnt-3a (200 ng) for 4 h were fixed and incubated with monoclonal anti-β-catenin and polyclonal anti-Jade-1 antibodies. Profile plots were generated with NIH ImageJ to demonstrate quantitative Jade-1 and β-catenin protein distribution. The profile plot represents the signal intensity of each fluorophore along a single line across the midpoint of a representative cell. The x axis is the distance in pixels through the length of a single cell, and the intensity of each fluorophore is plotted on the y axis. Representative image from four experiments. Scale bar, 10 μm. (d) Identification of the domain of β-catenin required for Jade-1 binding. Extracts from transiently transfected 293T cells were immunoprecipitated. Whole cell lysates (10%) were probed for input. β-Catenin delC and delN constructs lack the C terminus and N terminus of the protein, respectively ( Supplementary Fig. S1a ). Representative immunoblot of three experiments. Full scans of immunoblots are shown in Supplementary lines ( Supplementary Information, Fig. S2f ). Thus, Jade-1 regulates the stability of the Wnt-responsive pool of β-catenin. The degradation of β-catenin depends on GSK-3β. In Wnt-off phase, β-catenin undergoes sequential phosphorylation at residues T41, S37 and S33 by GSK-3β. Preferential binding of Jade-1 to phospho-β-catenin and the lack of binding to β-catenin S33A suggest a possible role for GSK-3β in the regulation of β-catenin by Jade-1 ( Fig. 1d and Supplementary  Information, Fig. S1f ). Moreover, full-length Jade-1 decreased the total quantity of β-catenin, predominantly as a result of a decrease in the quantity of phospho-β-catenin ( Supplementary Information, Fig. S3a ). Thus, Jade-1 preferentially regulates phospho-β-catenin. This observation further suggests that GSK-3β may be particularly important for the regulation of β-catenin by Jade-1. Indeed, the regulation of β-catenin by Jade-1 was mitigated by the silencing or chemical inhibition of GSK-3β ( Fig. 2e, f) . Similarly, the effect of Jade-1 silencing on the abundance of β-catenin was decreased in Wnt-on phase, when GSK-3β activity is inhibited ( Fig. 2g and Supplementary Information, Fig. S3b ). Overall, these data indicate that Jade-1 requires intact GSK-3β kinase activity for full inhibition of β-catenin. β-Catenin undergoes proteasomal degradation 11 . Inhibition of proteasome activity with MG132 completely abrogated the effect of Jade-1 on the abundance of β-catenin ( Supplementary Information, Fig. S3c ). Moreover, in the presence of Jade-1 and proteasomal inhibition, very high-molecular-mass species of β-catenin accumulated ( Supplementary  Information, Fig. S3d ), suggesting that Jade-1 may enhance the ubiquitylation and degradation of β-catenin. Numbers at the top of each bar indicate the number of embryos in each category. A χ2 test was applied to determine statistical significance: asterisk, Xwnt-8 with Jade-1 versus Xwnt-8 (P < 0.0001); two asterisks, Xwnt-8 with Jade-1 dd versus Xwnt-8 (P = 0.096); three asterisks, β-catenin with Jade-1 versus β-catenin (P < 0.046); four asterisks, β-catenin with Jade-1 dd versus β-catenin (P = 0.087). S, statistically significant; NS, not significant. Protein ubiquitylation depends on substrate recognition by a highly selective E3 ubiquitin ligase. PHD proteins such as MEK kinase 1 (MEKK1) and modulator of immune recognition (MIR) show E3 ubiquitin ligase activity 12, 13 . Jade-1 has two PHDs 3 that align well with the PHDs of MEKK1, MIR1, MIR2 and c-MIR ( Supplementary Information,  Fig. S4a ). We therefore reasoned that Jade-1, through its PHDs, might ubiquitylate β-catenin. Deletion of the PHDs reduced the effect of Jade-1 on β-catenin ( Supplementary Information, Fig. S4b ). Next, endogenous β-catenin was immunoprecipitated, and its ubiquitylation was examined in the presence of Myc-tagged ubiquitin and Jade-1, Jade-1 dd or β-TrCP 6 (Fig. 3a) . Minimal β-catenin ubiquitylation was observed with β-TrCP under these conditions, possibly as a result of lower expression of β-TrCP or the fact that the other components of the β-TrCP Skp/Cullin/F-box protein (SCF) complex were not co-expressed. Robust β-catenin polyubiquitylation was observed with full-length Jade-1, whereas deletion of the PHDs substantially decreased the ubiquitylation of β-catenin ( Fig  3a) . Ubiquitylation of β-catenin appeared as a smear, most prominently in the presence of full-length Jade-1. Because 293T cells are in Wnt-off status under basal conditions, these data indicate that Jade-1 promotes the ubiquitylation of endogenous β-catenin in Wnt-off phase.
The ubiquitylation of β-catenin in vitro was then examined. GSTpurified β-catenin was incubated with the cytosolic S100 fraction of HeLa cells. Ubiquitylation of β-catenin was observed in the presence of Jade-1 (Fig. 3b ). To address the question of whether Jade-1 directly ubiquitylates β-catenin and to map the E3 ubiquitin ligase domain within Jade-1, we reconstituted ubiquitylation reactions with all purified components ( Fig. 3c and Supplementary Fig. S4c ). Ubiquitylation of β-catenin was observed with Jade-1 in a dose-dependent manner ( Supplementary To examine the relationship between Jade-1-mediated and β-TrCPmediated β-catenin degradation, dominant-negative (DN) β-TrCP lacking the F box was used to antagonize both β-TrCP1 and β-TrCP2 (ref. 14) . DN β-TrCP doubled the expression of endogenous β-catenin ( Fig. 3d ). Jade-1 was still able to downregulate β-catenin in the presence of DN β-TrCP ( Fig. 3d ), which suggests that Jade-1 regulates β-catenin independently of β-TrCP.
The biological significance of the Jade-1-β-catenin interaction was evaluated in T-cell factor (TCF)/β-catenin transcription assays. Fulllength Jade-1, but not Jade-1 dd, inhibited a TOP-Flash promoterreporter 4.3-fold ( Fig. 4a ). Jade-1 had no effect on the transcriptional activity of β-catenin S33A (Fig. 4a ). These observations are consistent with the effect of Jade-1 on protein levels of wild-type β-catenin and β-catenin S33A ( Fig. 2a ). Intriguingly, significant inducible endogenous Wnt activity was observed in Jade-1-silenced cell lines ( Supplementary  Information, Fig. S5a ), which is consistent with the stabilization of endogenous β-catenin in these lines.
Because Jade-1 destabilizes β-catenin and inhibits β-catenin-mediated transactivation, we reasoned that Jade-1 might inhibit the canonical Wnt pathway in vivo. We used a functional assay for canonical Wnt signalling, namely the formation of an ectopic axis in Xenopus laevis embryos by ventral injection of Xwnt-8 or β-catenin messenger RNA 15 . Full-length Jade-1, but not Jade-1 dd, significantly inhibited both Xwnt-8-induced and β-catenin-induced ectopic axis formation in developing Xenopus laevis embryos (Fig. 4b, c , and Supplementary Information, Fig. S5b ). These data suggest that Jade-1 has the capacity to suppress Wnt activity during Wnt-on phase in vivo. This is plausible in view of the appreciable interaction of Jade-1 and β-catenin in Wnt-on phase (Figs. 1b and Supplementary Information Fig. S1b ) and Jade-1 binding and ubiquitylation of non-phosphorylated β-catenin ( Fig. 3b , c, and Supplementary  Information, Fig. S1f ). The specific Wnt target Axin2 (ref. 16 ) was also increased in Jade-1-silenced 293 cell lines ( Fig. 4d ). Other Wnt targets, such as cyclin D1 and c-Myc, were increased in Jade-1-silenced cell lines ( Supplementary Information, Fig. S5c ). Full-length Jade-1, but not Jade-1 dd, decreased protein levels of c-Myc ( Supplementary Information,  Fig. S5d ). Thus, Jade-1 is an inhibitor of canonical Wnt signalling.
Jade-1 protein is stabilized by wild-type pVHL but not by mutated pVHL associated with renal cancer 3, 4 . We proposed that pVHL might regulate β-catenin through Jade-1. First, we compared β-catenin abundance in VHL-deficient and VHL-intact renal cancer cell lines ( Fig. 5a ). Endogenous cytosolic and nuclear pools of β-catenin were severalfold lower in VHL-intact cell lines than in VHL-deficient cell lines ( Fig. 5a ). This result can be explained by our previous observations that Jade-1 levels are significantly lower in VHL-deficient cell lines 5 . Next, the reintroduction of pVHL in 786-O cells increased endogenous Jade-1 (refs 4, 5) and substantially decreased endogenous β-catenin levels ( Fig. 5b and Supplementary Information, Fig. S6a ). Knockdown of VHL with short interfering RNA (siRNA) oligonucleotides resulted in downregulation of Jade-1 and the accumulation of β-catenin ( Fig. 5c and Supplementary  Information, Fig. S6b ) 17 .
To examine specifically whether Jade-1 mediates pVHL downregulation of β-catenin, we compared β-catenin regulation by wild-type pVHL and by truncated forms of pVHL that do not stabilize Jade-1 (ref. 4) ( Fig. 5d ). pVHL del96-122 and naturally occurring, cancer-causing truncations such as pVHL 1-143 and pVHL 1-175, which have little or no effect on Jade-1 stability 4 , had minimal effect on β-catenin ( Fig. 5d ). We also knocked down Jade-1 in the presence of pVHL. Endogenous Jade-1 levels were increased by pVHL, an effect blocked by Jade-1 knockdown ( Supplementary Information, Fig. S6c ). Downregulation of β-catenin by pVHL was substantially mitigated by Jade-1 knockdown ( Supplementary Information, Fig. S6c ). Furthermore, wild-type pVHL, but not pVHL del96-122, suppressed the transcriptional activity of β-catenin ( Supplementary Information, Fig. S6d ). Specific Wnt targets such as LEF1 (ref. 18 ) and cyclin D1 were decreased in pVHLexpressing renal cancer cell lines ( Fig. 5e ). Wild-type pVHL, but not pVHL del96-122, also decreased Axin2 in 293T cells ( Supplementary  Information, Fig. S6e ). Overall, these data indicate that pVHL inhibits β-catenin and canonical Wnt signalling and that Jade-1 is a critical mediator of these effects.
To determine whether pVHL is able to reduce endogenous Wnt signalling in vivo, and to examine the difference in the suppression of Wnt activity by wild-type pVHL and pVHL del96-122, we injected wild-type VHL or VHL del96-122 mRNA into the dorsal blastomeres of Xenopus laevis embryos, in which canonical Wnt signalling is necessary for dorsal development 19 . Inhibition of dorsal axis formation in Xenopus laevis embryos is demonstrated by a reduction of dorsoanterior structures (small eyes, microcephaly or anencephaly) measured with a dorsoanterior index (DAI) scale 19 . Wild-type pVHL suppressed formation of the dorsal axis significantly more than pVHL del96-122 when expressed at the same level ( Supplementary Information, Fig. S6f, g) . As expected, inhibition of endogenous axis by wild-type pVHL was associated with greater suppression of β-catenin/TCF target genes Xsiamois and Xnr3 than by pVHL del96-122 ( Fig. 5f ). Thus, pVHL inhibits canonical Wnt signalling in vivo, and pVHL del96-122, which binds and regulates Jade-1 only minimally 4 genes in Xenopus laevis embryos. These data further support the role of Jade-1 as a critical mediator of the regulation of β-catenin by pVHL.
In this study we have shown that Jade-1 is an E3 ubiquitin ligase for β-catenin and that the Jade-1 PHDs are essential for this function. Moreover, Jade-1 is a critical mediator of the inhibition of β-catenin and canonical Wnt signalling by pVHL. Jade-1 is anti-proliferative and pro-apoptotic, whereas β-catenin is pro-proliferative, anti-apoptotic and oncogenic 7 . The tumour suppressor activity of Jade-1 may therefore be due in part to inhibition of β-catenin.
Several ubiquitin ligases for β-catenin have now been identified 9,20,21 , but only β-TrCP and Jade-1 show Wnt responsiveness, suggesting that they are both important in the physiology and pathophysiology of canonical Wnt signalling. Endogenous β-TrCP resides in the cytosol and is capable of binding and ubiquitylating phosphorylated β-catenin 6, 9, 22, 23 . In contrast, endogenous Jade-1 resides in the cytosol but is found primarily in the nucleus 3, 8 and is capable of binding and ubiquitylating both phosphorylated and non-phosphorylated β-catenin. Thus, Jade-1 and β-TrCP have only partly overlapping subcellular locations and have differing specificities for the forms of β-catenin. These differences may explain why Jade-1 silencing cannot be completely compensated for by β-TrCP ( Fig. 2b, d , and Supplementary Information, Fig. S2b-d) . Moreover, Jade-1 seems to act more distally in the canonical Wnt cascade, affecting β-catenin in the nucleus. This may make Jade-1 responsible for the fine control of β-catenin levels.
Jade-1 functions as a single-subunit E3 ubiquitin ligase for β-catenin, whereas β-TrCP requires the formation of a multi-subunit protein complex. The PHD functions as an adaptor-type E3 ubiquitin ligase, directly transferring the ubiquitin moiety to the substrate 13 . Control of Jade-1 may therefore be a simpler and perhaps more efficient way of regulating β-catenin abundance. It is likely that the cell exploits the distinct functional and contextual differences between β-TrCP and Jade-1 to ensure effective regulation of Wnt signalling.
β-catenin is emerging as a key molecule in the pathogenesis of renal cancer and renal cystic disease. For example, increased β-catenin activity in renal epithelium in mice results in the robust formation of renal cysts and tumours [24] [25] [26] . In renal cancer, methylation of the APC gene promoter is common 27 . pVHL was recently shown to inhibit the HGF-mediated tyrosine phosphorylation of β-catenin 28 . These observations further strengthen the role of Wnt signalling in renal-cell carcinoma. Jade-1 and pVHL may also participate in other forms of cystic kidney disease, for which evidence of dysregulated Wnt signalling is increasing 26, 29 .
Our data suggest that the inhibition of Wnt signalling by Jade-1 is a new tumour suppressor axis for pVHL. Furthermore, these findings directly link the kidney-specific pVHL tumour suppressor pathway and the Wnt signalling cascade, a more general tumorigenesis pathway. Jade-1 and β-catenin may therefore represent therapeutic targets in renal-cell carcinoma.
METHods
In vitro ubiquitylation reaction. Ubiquitylation reactions were reconstituted in 30 μl with ubiquitylation buffer (50 mM Tris-HCl pH 7.5, 0.5 mM dithiothreitol) containing 225 nM E1 activating enzyme (Boston Biochem), 500 nM E2 conjugase, 600 μM Myc-tagged ubiquitin (Boston Biochem), 1 mM MgCl 2 -ATP, 750 nM Jade-1 and 2.8 μM GST-β-catenin on glutathione beads and incubated at 37 °C for 60 min. Reactions without E1, E2 or ubiquitin, or with a DN E2 (mutation of active-site cysteine to serine) served as negative controls.
Xenopus embryo injection and phenotype evaluation. Embryos were fertilized in vitro, dejellied in 2% cysteine (pH 7.8) and maintained in 0.1 × Marc's Modified Ringer's medium (MMR). For microinjection, embryos were transferred to 1.5% Ficoll (Pharmacia) in 0.5 × MMR and injected at stages 2 or 3. Two blastomeres were injected ventrally with 10 nl of LacZ or Xwnt-8 mRNA with or without Jade-1 mRNA (full-length or dd), or dorsally with LacZ or VHL (wild-type or VHL del96-122) mRNA. Embryos were fixed and analysed as described previously [30] [31] [32] .
Figure S1
Jade-1 directly binds β-catenin, and the interaction is enhanced in Wnt-off phase. a, Schematic of Jade-1 and β-catenin constructs. Jade-1 dd lacks both PHDs but has an intact inter-PHD region and contains aa 1-202, 254-311, and 372-509 3, 8 . β-catenin constructs have an N-terminal Myc tag. b, Jade-1 binds to β-catenin in a Wnt-responsive manner. Immunoprecipitations were performed with WCLs of 293T cells pretreated with vehicle (water) (Veh) or 20 mM lithium chloride (Li) for 4 h using 1 μg of either polyclonal Jade-1 antibody or pre-immune rabbit serum (data not shown). β-catenin was immunoprecipitated using monoclonal β-catenin antibody or isotype control (data not shown). Whole cell lysates (WCL) (10%) were probed for input. One of 2 similar experiments is shown. c, Expression of Jade-1 and β-catenin in Wnt-off phase. The 293 cells transfected with Flag-tagged Jade-1 or Myc-tagged β-catenin constructs pretreated with vehicle (PBS + 0.1% bovine serum albumin) for 4 h were processed for immunofluorescence. A single representative confocal image is shown. Wildtype β-catenin and the C terminus (delC) truncations of β-catenin localized to the cytosol and membrane. The N terminus (delN) truncation of β-catenin localized predominantly to the cytosol, while β-catenin S33A localized predominantly to the nucleus. Jade-1 localized to the cytosol and to lesser extent to the nucleus. Scale bar = 10 μm. Protein extracts of 293T cells transiently transfected with full-length Jade-1 (J1) or Jade-1 dd (J1dd) were probed for β-catenin. α-tubulin, fibrillarin or E-cadherin served as loading controls and markers of cytosolic, nuclear and membrane fractions, respectively. These control blots were generated by cutting the membrane at the expected molecular weights of the controls and immunoblotting separately. Cytosolic fractions were probed to examine expression of Jade-1 and Jade-1 dd. One of two similar experiments is shown. c, Dose-dependent in vitro ubiquitination of β-catenin by Jade-1. Ubiquitination reactions were reconstituted by incubating GST-β-catenin beads with E1 activating enzyme, E2 conjugase (UbcH6), E3 ligase Jade-1 (in increasing amounts, 250, 750, or 1200 nM) or Jade-1 (full-length or dd) (750 nM), Myc-tagged human recombinant ubiquitin (Ub) and MgCl 2 -ATP. No E1, no E2, no Ub and DN E2 reactions served as negative controls. β-catenin ubiquitination was detected using polyclonal β-catenin C-terminal antibody. Reactions without E1, E2, or ubiquitin, or with dominant-negative (DN) UbcH6, served as negative controls (lanes 8-11) . Jade-1 input was detected by immunoblot. Lane 7 was rearranged from the same blot. One of two similar experiments is shown. Figure S6 pVHL regulates β-catenin through Jade-1. a, pVHL downregulates endogenous β-catenin. Fractions of VHL-deficient renal cancer cell lines stably expressing pVHL were probed. The UMRC6 cell line has a lower level of expression of pVHL compared to the A498 cell line (data not shown). One of two similar experiments is shown. b, pVHL knock-down increases endogenous β-catenin. Cytosolic fractions of VHL-intact renal cancer cell lines transfected with control (Csi) or VHL siRNA (VHLsi) oligonucleotides were probed for β-catenin. One of two similar experiments is shown. c, Jade-1 silencing in the presence of pVHL mitigates β-catenin regulation. The 293T cells were transiently transfected as shown. pVHL was detected using monoclonal pVHL antibody. One of two similar experiments is shown. d, Wild-type pVHL, but not pVHL del96-122, suppresses β-catenin-mediated transcriptional activation. The 293T cells transiently transfected with empty vector or β-catenin; wildtype pVHL, pVHL del96-122 or empty vector; and TOP-Flash or FOP-Flash were subjected to luciferase assay. Mean results of three experiments are shown. Error bars = SEM. p = 0.041 (* = statistically significant), p = 0.067 (NS) by Student's t-test. e, Wild-type pVHL, but not pVHL del96-122, suppresses Axin2. WCL of 293T cells transfected with empty vector (Vec), wild-type pVHL (WT) and pVHL del96-122 (del96-122) were immunoblotted for Axin2 and actin. One of two similar experiments is shown. f, Wild-type pVHL, but not pVHL del96-122, significantly inhibits endogenous axis in Xenopus laevis embryos. In vitro transcribed capped LacZ (0.145-0.288 ng) (N = 73), wild-type VHL (0.130-0.194 ng) (N = 115) or VHL del96-122 (0.146-0.293 ng) (N = 100) mRNA was injected into dorsal blastomeres of Xenopus laevis embryos. Uninjected (N = 135) and LacZ injected embryos served as controls. In uninjected embryos, normal dorsoanterior index (DAI) = 96%, partial axis duplication = 3% of embryos. In LacZ injected embryos, normal DAI = 92%, DAI 3-4 = 3%, gastrulation defects (GD) = 3%, partial axis duplication = 3% of embryos. In wild-type VHL injected embryos, normal DAI = 49%, DAI 3-4= 30%, DAI 0-2 = 5%, GD = 12% and partial double axis = 3% of embryos. In del96-122VHL injected embryos, normal DAI = 75%, DAI 3-4 =15%, DAI 0-2 = none, GD = 7%, partial axis duplication = 3% embryos. Wild-type pVHL suppressed endogenous axis formation significantly more than pVHL del96-122 (Chi square test, p = 0.0046). Six experiments were performed. g, Comparable expression of Myc-tagged pVHL wild-type and pVHL del96-122 protein in Xenopus laevis embryos. Xenopus laevis embryos injected with capped mRNAs were harvested at stage 10. Protein extracts were resolved by SDS-PAGE. Representative immunoblot of six experiments. GGAGCGCAUUGCACAUCAA; siRNA J-003936-12: CCAAUGGAUUCAUGGAGUA.
Synthesis of capped mRNA. The vectors were linearized with Not I restriction enzyme, treated with Proteinase K (Sigma) and extracted with phenol. Linearized plasmid DNA (1 μg/μl) in RNAse-free water was used for in vitro capped mRNA synthesis using the mMessage mMachine® SP6 kit (Ambion) according to manufacturer instructions.
